$2B Allergy Drug, ChatGPT Ads, Mansion Section | Billy Boman, Benjamin Miller, Faris Sbahi, Evan Loomis, Anvisha Pai, Ryan Tseng
Sign up for TBPN’s daily newsletter at TBPN.com (01:53) - Novartis to Buy Excellergy for $2B (11:04) - 𝕏 Timeline Reactions (24:08) - Anthropic Stories (33:06) - Mansion Section (54:23) - Billy Boman, an AI visual creator and educator, discusses his journey from a creative upbringing and formal design education to…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like TBPN →
What Manus and Groq Acquisitions Tell Us About AI
20VC: Anthropic's $6BN Revenue Month | OpenAI Kills Sora & Hits $100M ARR on Ads | Oura Going Public & Whoop Raises at $10BN | Manus Founders Trapped in China & The Billionaire Tax: Anyone Left in California?
Ep 812: Fable 5 is (kinda) Back, OpenAI Might Give Gov Equity, Microsoft’s new AI Company and more AI News
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.